Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v25-FR Version v25-FR
Language French French
Date Updated 2020-03-16 2020-03-16
Drug Identification Number 02080036 02080036
Brand name ETOPOSIDE INJECTION ETOPOSIDE INJECTION
Common or Proper name ETOPOSIDE ETOPOSIDE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ETOPOSIDE ETOPOSIDE
Strength(s) 20MG 20MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML 10ML
ATC code L01CB L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-04 2018-12-04
Estimated end date 2020-03-31 2020-03-31
Actual end date 2020-03-15 2020-03-15
Shortage status Resolved Resolved
Company comments Out of stock Out of stock
Health Canada comments